American Journal of Cardiovascular Drugs

Acknowledgment
pp. 391-392(2)
Author: Adis International Limited,

The Therapeutic Potential of VEGF Inhibition in Diabetic Microvascular Complications
pp. 393-398(6)
Authors: Tremolada, Gemma; Lattanzio, Rosangela; Mazzolari, Gabriella; Zerbini, Gianpaolo

Current Management of Syncope: Focus on Drug Therapy
pp. 399-411(13)
Authors: Venugopal, Deviprasad; Jhanjee, Rajat; Benditt, David G.

Fixed-Dose Combination Antihypertensives and Reduction in Target Organ Damage: Are They All the Same?
pp. 413-422(10)
Author: Smith, David H.G.

ADP Receptor Antagonism: What's in the Pipeline?
pp. 423-432(10)
Author: Angiolillo, Dominick J.

Expression of Platelet Surface Receptors and Early Changes in Platelet Function in Patients with STEMI Treated with Abciximab and Clopidogrel versus Clopidogrel Alone
pp. 433-439(7)
Authors: Konopka, Anna; Spychalska, Justyna; Sitkiewicz, Dariusz; Zdebska, Ewa; Pilichowska, Iwona; Piotrowski, Walerian; Stepińska, Janina

Estimating the Cost Effectiveness of Ramipril used for Specific Clinical Indications: Comparing the Outcomes in Four Clinical Trials with a Common Economic Model
pp. 441-448(8)
Authors: Grover, Steven A.; Coupal, Louis; Lowensteyn, Ilka

Improving Care in Resistant Hypertension: Medication Trends and Nonpharmacologic Strategies in a Specialty Clinic
pp. 449-452(4)
Authors: Fong, Michael W.; Filippone, John D.; Beck, G. Ronald; Katz, Michael G.; Bisognano, John D.

Colesevelam: A Review of its Use in Hypercholesterolemia
pp. 453-465(13)
Authors: Robinson, Dean M.; Keating, Gillian M.